Michelle Paxon

FDA investigator

Appears on 3 documents from 2024 to 2025, mostly at sites in Texas. Most often cites what records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain? (21 CFR 1271.55(b)(2)).

3
Documents on file
2.7
Observations per 483
2024
First seen
2025
Most recent

What they cite most

From 8 observations

Activity by year

2024: 1, 2025: 2

Where

Texas 3

Is Michelle Paxon coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Form 483 · FEI 3007268508Apr 24, 2025 · Fort Worth, Texas
483 Elite IVF & Fertility Solutions LLCMar 28, 2025 · Odessa, Texas
483 BioLife Plasma Services L.P.Nov 22, 2024 · Arlington, Texas

About this profile

What does Michelle Paxon inspect?

Michelle Paxon appears on 3 documents on file covering 3 sites, mostly in Texas.

What do they cite most often?

21 CFR 1271.55(b)(2) (what records must accompany an HCT/P after the donor-eligibility determination is complete; and what records must I retain?), followed by 21 CFR 1271.50(a) and 21 CFR 1271.75(a)(1).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michelle Paxon is dated Apr 24, 2025.